SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-074956
Filing Date
2006-11-14
Accepted
2006-11-14 15:01:34
Documents
6
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-21676_110q.htm 10-Q 660943
2 EX-10 a06-21676_1ex10d9.htm EX-10.9 57802
3 EX-31 a06-21676_1ex31d1.htm EX-31.1 9450
4 EX-31 a06-21676_1ex31d2.htm EX-31.2 9871
5 EX-32 a06-21676_1ex32d1.htm EX-32.1 4083
6 EX-32 a06-21676_1ex32d2.htm EX-32.2 4144
  Complete submission text file 0001104659-06-074956.txt   747844
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16614 | Film No.: 061214257
SIC: 2835 In Vitro & In Vivo Diagnostic Substances